In-vitro studies of two 5-nitroimidazole derivatives

Journal of Antimicrobial Chemotherapy

Volumn 40, Issue 1, 1997, Pages 19-25

  Castelli, Mario ^a   Malagoli, Monica ^a   Ruberto, Antonio Ippazio ^a   Baggio, Andrea ^a   Casolari, Chiaral ^a   Cermelli, Claudio ^a   Bossa, Maria Rosaria ^b   Rossi, Tiziana ^a   Paolucci, Francesco ^c   Roffia, Sergio ^c  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

METRONIDAZOLE; NITROIMIDAZOLE DERIVATIVE; SULFONIDAZOLE; SULFURIDAZOLE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CLOSTRIDIUM; NONHUMAN;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BACTERIA; CANDIDA; CLOSTRIDIUM; ELECTROCHEMISTRY; ESCHERICHIA COLI; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS; NITROIMIDAZOLES; OXIDATION-REDUCTION; SULFONES;

EID: 0030748068     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/40.1.19     Document Type: Article

References (32)

1. Sutter, V. L. & Finegold, S. M. (1976). Susceptibility of anaerobic bacteria to 23 antimicrobial agents. Antimicrobial Agents and Chemotherapy 10, 736-52.
2. Weinrich, A. E. & Del Bene, V. F. (1976). Beta-lactamase activity in anaerobic bacteria. Antimicrobial Agents and Chemotherapy 10, 106-11.
3. Salyers, A. A., Wong, J. & Wilkins, T. D. (1977). Beta-lactamase activity in strains of Bacteroides melaninogenicus and Bacteroides oralis. Antimicrobial Agents and Chemotherapy 11, 142-6.
4. Levine, B. B., Redmond, A. P., Fellner, M. J., Voss, H. E. & Levytska, V. (1966). Penicillin allergy and the heterogeneous immune responses of man to benzylpenicillin. Journal of Clinical Investigation 45, 1895-906.
5. Sutter, V. L., Kwok, Y. Y. & Finegold, S. M. (1972). Standardized antimicrobial disc susceptibility testing of anaerobic bacteria. 1. Susceptibility of Bacteroides fragilis to tetracyline. Applied Microbiology 23, 268-75.
6. Sutter V. L. (1977). In vitro susceptibility of anaerobes: comparison of clindamycin and other antimicrobial agents. Journal of Infectious Diseases 135, Suppl., S7-12.
7. Baines, E. I. (1977). Metronidazole: sixteen years of developments. In Metronidazole (Finegold, S., Ed.), pp. 61-71. Excepta Medica, Amsterdam.
8. Cosar, C. & Julou, L. (1959). Activité de L'(hydroxy-2′-ethyl)-1 methyl-2 nitro-5-imidazole (8823 R.P.) vis-à-vis des infections experimentales à Trichomonas vaginalis. Annales de l'Institut Pasteur 96, 238-41.
9. Cosar, C., Ganter, P. & Julou, L. (1961). Étude expérimentale du métronidazole, 8223 R.P: activités trichomonacide et amoebicide. Toxicité et propriétés pharmacologiques génerales. Presse Médicale 69, 1969-72.
10. Burchard, G. D. & Mirelman, D. (1988). Entamoeba histotytica; virulence potential and sensitivity to metronidazole and emetine of four isolates possessing non-pathogenic zymodemes. Experimental Parasitology 66, 231-42.
11. Jokipii, L. & Jokipii, A. M. M. (1980). In vitro susceptibility of Giardia lamblia trophozoites to metronidazole and tinidazole. Journal of Infectious Diseases 141, 317-25.
12. Bertolini, A., Castelli, M., Borella, F., Dall'Asta, L., Comini, A., Alberti, D. et al. (1989). Synthesis and biological properties of 1-methyl-2[(4-aminophenyl)-sulphonyl-]amino-5-nitromidazole. Bollettino Chimico Farmaceutico 128, 71-3.
13. Castelli, M., Baggio, G., Ruberto, A. I., Rossi, T., Provvisionato, A., Malagoli, M. et al. (1992). In vitro activity of sulphimidazole alone and in association with thrimethoprim against enteric pathogens. Pharmacological Research 25, 373-81.
14. Castelli, M., Baggio, G., Ruberto, A. I., Rossi T., Provvisionato, A., Malagoli, M. et al. (1995). In vitro activity of trimethoprim in association with sulfimidazole against aerobic Gram-negative and Gram-positive microorganisms and clostridia. Chemotherapy (Basle) 41, 337-44.
15. Bertolini, A., Castelli, M. & Poggioli, R. (1974). In vitro antibacterial activity of 2-amino-4(2-ethynyl-1-methyl-5-nitroimidazole) pyrimidine, a metronidazole derivative with antitrichomonad activity. Experientia 30, 757-8.
16. Boemi, P. (1979). Azanidazol, a new trichomonicidal: clinical experimentation. Clinical and Experimental Obstetrics and Gynecology 6, 117-8.
17. Simonetta, R. & Longo, D. (1979). Azanidazol in the therapy of genital tricomoniasis: first results of a gynaecological investigation. Clinical and Experimental Obstetrics and Gynecology 6, 119-21.
18. Proctor, A. G. J. & Mackenzie, D. W. R. (1980). Laboratory control. In Antifungal Chemotherapy (Speller, D. C. E., Ed.), pp. 407-36. John Wiley & Sons, Chichester.
19. Saji, T., Ymada, T. & Aoyagui, S. (1975). Electron transfer rate constants for redox systems of Fe(III)/Fe(II) complexes with 2,2′-bipyridine and/or cyanide ion as measured by the galvanostatic double pulse method. Journal of Electroanalytical Chemistry and Interfacial Chemistry 61, 147-53.
20. Paolucci, F., Marcaccio, M., Roffia, S., Orlandi, G., Zerbetto, F., Prato, M. et al. (1995). Electrochemical monitoring of valence bond isomers interconversion in bipyridyl-C61 anions. Journal of the American Chemical Society 117, 6572-80.
21. Barendrecht, E. (1967). Stripping Voltammetry. In Electroanalytical Chemistry Vol. 2 (Bard, A. J., Ed.), pp. 53-109. Marcel Dekker, New York, NY.
22. Bard, A. J. & Faulkner, L. R. (1980). Electrochemical Methods, pp. 218-20. John Wiley & Sons, New York, NY.
23. Farnia, G. & Roffia, S. (1981). A very simple solid electrode with periodical renewal of the diffusion layer. Journal of Electro-analytical Chemistry and Interfacial Electrochemistry 122, 347-52.
24. Oldham, K. B. (1981). Steady state voltammetry. In Micro-electrodes: Theory and Applications (Montenegro, M. I., Queiros, M. A. & Daschbach, J. L., Eds), pp. 35-50. Kluewer Academic Publishers, Dordrecht.
25. Amatore, C. A., Jutand, A. & Pflu&ger, F. (1987). Nanosecond time resolved cyclic voltammetry. Direct observation of electrogenerated intermediates with bimolecular diffusion controlled decay using scan rates in the megavolt per second range. Journal of Electroanalytical Chemistry and Interfacial Electrochemistry 218, 361-5.
26. Edwards, D. I. (1993). Nitroimidazole drugs - action and resistance mechanisms. I. Mechanisms of action. Journal of Antimicrobial Chemotherapy 31, 9-20.
27. Edwards, D. I. (1993). Nitroimidazole drugs - action and resistance mechanisms. II. Mechanisms of resistance. Journal of Antimicrobial Chemotherapy 31, 201-10.
28. Knox, R. J., Knight, R. C. & Edwards, D. I. (1981). Interaction of nitroimidazole drugs with DMA in vitro; structure - activity relationships. British Journal of Cancer 44, 741-5.
29. Edwards, D. I., Knox, R. J. & Knight, R. C. (1982). Structure - cytotoxicity relationships of nitroimidazoles in an in vitro system. International Journal of Radiation, Oncology, Biology and Physics 8, 791-3.
30. Breccia, A., Berrilli, G. & Roffia, S. (1979). Chemical radiosensitization of hypoxic cells and redox potentials. Correlation of voltammetric results with pulse radiolysis data of nitro-compounds and radiosensitizers. International Journal of Radiation Biology 36, 85-9.
31. Reynolds, A. V. (1981). The activity of nitro-compounds against Bacteroides fragilis is related to their electron affinity. Journal of Antimicrobial Chemotherapy 8, 91-9.
32. Winkelmann, E., Raether, W. & Sinharay, A. (1978). Chemotherapeutically active nitro compounds. 4.5-Nitroimidazoles (Part II). Arzneimittel-Forschung 28, 351-6.